Group Therapy for Individuals in Drug Abuse or Alcoholism Treatment

The summary for the Group Therapy for Individuals in Drug Abuse or Alcoholism Treatment grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Group Therapy for Individuals in Drug Abuse or Alcoholism Treatment: The purpose of this Request for Applications (RFA) is to invite research applications addressing group-format behavioral treatments for drug abuse and/or alcohol use disorders (AUD). Applications that focus on interventions to reduce the spread of infectious disease in substance abuse treatment populations are also of interest. This RFA builds on a meeting convened by the National Institute on Drug Abuse (NIDA) in 2003 on the challenges in conducting research on group therapy, and is part of an ongoing commitment of NIDA and National Institute on Alcohol Abuse and Alcoholism (NIAAA) to support the development and testing of behavioral treatments for drug abuse and AUD that can be delivered in community substance abuse treatment settings. Most behavioral treatments for drug abuse/dependence in community settings are delivered via group format, yet relatively few systematic studies of group therapy for drug abuse or AUD have been conducted. Further, the many methodological and logistical challenges in conducting group therapy research present significant obstacles to the development of this area of research. For these reasons, NIDA and NIAAA wish to support additional scientifically-sound and clinically-relevant research in this area. Applications are encouraged that: (1) develop new group therapies, based on strong clinical theory, or on translation of findings from basic behavioral, cognitive, affective, and social science studies and/or on current knowledge in neuroscience; (2) adapt existing group therapies originally developed for clinical problems other than drug abuse/AUD to incorporate drug abuse, AUD, and/or infectious disease risk reduction as targets of treatment; (3) adapt existing behavioral treatments originally developed as non-group format treatments to be delivered via group format; (4) develop treatment manuals for existing group therapies that have not yet been systematized, and test these therapies (i.e., reverse-engineering of existing group treatments); and (5) address the methodological and statistical tools necessary for examining the effects of group-format treatments. In addition, all applications should strive to incorporate tests of the mechanisms of action of group therapies, identifying important mediators and moderators of treatment effects.